Andy Intlekofer Profile
Andy Intlekofer

@IntlekoferLab

Followers
893
Following
2K
Media
13
Statuses
153

Physician scientist in HOPP and DOM/Lymphoma at Memorial Sloan Kettering. Our lab studies the metabolic control of cell fate and oncogenesis. Tweets are my own.

New York, NY
Joined May 2014
Don't wanna be here? Send us removal request.
@IntlekoferLab
Andy Intlekofer
7 years
It was an honor to be part of this team effort to understand how some cancers develop resistance to IDH inhibitors. Thank you Alan Shih, Eytan Stein, Craig Thompson, and Ross Levine! ⁦@rosslevinemd@sloan_kettering#mskcc
8
27
89
@AbdelWahablab
Abdel-Wahab Lab
4 years
Excited to share our collaboration w/ @bradleybio demonstrating that pharmacologic modulation of splicing induces immunogenic neoantigens and augments response to checkpoint blockade. Jointly led by @SXLuLab, @ejdeneef, @jdthomaslab. Out today in @Cell: https://t.co/kKWVNjnv9C
Tweet card summary image
cell.com
By provoking production of “neoantigens” that are recognized by immune cells, drugs that modulate RNA splicing can enhance cancer immunotherapy.
22
54
241
@SantoshVardhana
Santosh Vardhana
4 years
So proud that the first paper from @VardhanaLab, an equal collaboration with @Ron_cology and Alex Huang's lab, is out today in @NatureMedicine: https://t.co/kQGH0haNZO. I posted a long tweetorial about this study when it was a preprint, but a few additional thoughts:
14
18
86
@KentsisResearch
Kentsis Research Group
5 years
Please read and use our latest work with @CompProteomics on agnostic chemical proteomics: Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics
Tweet card summary image
pubs.acs.org
Recent studies have revealed diverse amino acid, post-translational, and noncanonical modifications of proteins in diverse organisms and tissues. However, their unbiased detection and analysis remain...
1
8
39
@BayliesLab
Mary Baylies
5 years
Congrats to @SylviaZohrabian and @IntlekoferLab ! @WeillCornellGS and #WCGSBCMB directors are so pleased ! Yay! Keep the good news coming!
@IntlekoferLab
Andy Intlekofer
5 years
Congratulations to my very first graduate student ⁦@SylviaZohrabian⁩ for receiving the ⁦@DeptofDefense Horizon Award! A welcome piece of good news in a difficult year. ⁦@WeillCornellGS⁩ ⁦@sloan_kettering⁩. Meet Our 2021 Fellows...
1
2
7
@IntlekoferLab
Andy Intlekofer
5 years
Congratulations to my very first graduate student ⁦@SylviaZohrabian⁩ for receiving the ⁦@DeptofDefense Horizon Award! A welcome piece of good news in a difficult year. ⁦@WeillCornellGS⁩ ⁦@sloan_kettering⁩. Meet Our 2021 Fellows...
0
2
70
@MSKCancerCenter
Memorial Sloan Kettering Cancer Center
5 years
#CancerCare can’t wait. If you or someone you know has symptoms or has been diagnosed with cancer, please don’t wait. The #cancer experts at Memorial Sloan Kettering are here for you. Connect with an MSK cancer expert. https://t.co/PKGFgwD3Xi #MSKAlways
2
29
54
@IntlekoferLab
Andy Intlekofer
5 years
For all aspiring cancer researchers, check out the PhD program @GSKGradSchool @sloan_kettering. It’s an amazing and supportive environment to train in!
@GSKGradSchool
GSK Graduate School
5 years
Learn more about our #PhD program in #Cancer #Biology and #BiomedicalSciences by joining a virtual information session. Hear from our Deans and students about the innovative program embedded within @sloan_kettering in #NYC. Register on our webpage https://t.co/PWCmDEIQwh
0
0
4
@GSKGradSchool
GSK Graduate School
5 years
Learn more about our #PhD program in #Cancer #Biology and #BiomedicalSciences by joining a virtual information session. Hear from our Deans and students about the innovative program embedded within @sloan_kettering in #NYC. Register on our webpage https://t.co/PWCmDEIQwh
Tweet card summary image
sloankettering.edu
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences offers the next generation of basic scientists a program to study the biological sciences through the lens of cancer
2
20
12
@NatureRevCancer
Nature Reviews Cancer
5 years
New Review online! T Nielsen &co discuss how the disease biology of many sarcomas is driven by #chromatin pathway alterations w/ a view to use this knowledge to better develop targeted therapies for patients with #sarcoma. https://t.co/nSf5BM360k @NatResCancer #DNAmethylation
2
35
84
@KivancBirsoy
Kivanc Birsoy
5 years
Check out @mluzsoula new paper on metabolic determinants of lipid peroxidation. An equal collaboration between our lab (Ross Weber and @JaviGBermudez) and @PrattGroup https://t.co/o9ApIWdyPJ
10
26
157
@TuomasTammela
Tuomas Tammela
5 years
I am pleased to share our paper out today in @Cancer_Cell identifying a novel cancer cell state that is central to phenotypic transitions - and that seems to play a key role in tumor progression and drug resistance.
39
93
492
@IntlekoferLab
Andy Intlekofer
5 years
Congratulations to ⁦@IntlekoferLab⁩ fellow Zach Epstein-Peterson ⁦(@zde_p⁩) for receiving the 2020 ⁦@AACR⁩ ⁦@AstraZeneca⁩ Lymphoma Research Fellowship! Excited to see the impactful discoveries you will make ⁦@sloan_kettering⁩.
aacr.org
Since 1993, the AACR has allocated more than $460 million and awarded over 800 grants to support thousands of scientists devoted to advancing the understanding, prevention, diagnosis, and treatment...
2
2
50
@SantoshVardhana
Santosh Vardhana
5 years
I am so excited that our paper exploring how metabolic dysfunction contributes to T-cell exhaustion is out today in @NatImmunol. A thread (1/X):
13
60
202
@EmilyDel5
Emily Delgado
5 years
MSKCC is offering a free virtual seminar series for High School Students. We welcome all interested to attend - visit our website for registration information. @CharlesSawyers @rosslevinemd @wolchokj @ederlinda @IntlekoferLab @DSolit @MFBerger1 @CDebyaniPhD
1
27
44
@df_hcc
DF/HCC
5 years
Today's DF/HCC @LLSusa #ConnectScience #Webinar at 12: TALK 1 @TothovaLab: Biology and Therapeutics Targeting of #CohesinMutations in #MyeloidMalignancies TALK 2 @IntlekoferLab @sloan_kettering: Oncogenic Mechanisms and Therapeutic Targeting of 2-Hydroxyglutarate Metabolism
0
1
0
@df_hcc
DF/HCC
5 years
Today's DF/HCC @LLSusa #ConnectScience #Webinar at 12pm: David Tuveson @CSHL, "Pathways of Progression in #PancreaticCancer" Next wk: M: Douglas Hanahan @EPFL Tu: @TothovaLab @DanaFarber Tu: @IntlekoferLab @sloan_kettering Th: @DrTonyLetai @theSFPM @DanaFarber
0
5
10